Pharmaceutical · Fiscal year end Mar 31

Fuso Pharmaceutical Industries,Ltd.

4538

扶桑薬品工業株式会社

FIGI BBG000BG6VQ84538.T4538 JPCorp. no. 5120001077541

Latest half-year results

First half · fiscal year to 2026-03 · filed 2025-11-12

For the first half of the fiscal year to 2026-03: Revenue ¥31.2 billion (+5.0% YoY), Ordinary income ¥1.1 billion (-47.2% YoY), Net income ¥0.8 billion (-45.9% YoY).

	This period	Year on year
Revenue	¥31.2bn	+5.0%
Ordinary profit	¥1.1bn	-47.2%
Net profit to owners	¥831m	-45.9%

From the securities report on EDINET, which states no forecast. History via /v1/companies/4538/earnings-releases.

Financials

Japan GAAP · non-consolidated · fiscal year to 2026-03-31

Revenue: ¥62.3bn
Net income: ¥2.0bn
ROE: 5.9%
Equity ratio: 38.8%
Dividend / share: ¥90
Employees: 1,374

Revenue · ¥bn

Net income · ¥bn

Fiscal year	Revenue	Net income	Total assets	Net assets	ROE	EPS	Operating CF
2026-03-31	¥62.3bn	¥2.0bn	¥90.3bn	¥35.1bn	5.9%	¥235.63	−¥6.2bn
2025-03-31	¥60.6bn	−¥3.3bn	¥81.7bn	¥33.0bn	-9.4%	¥-384.95	−¥3.3bn
2024-03-31	¥55.4bn	¥1.4bn	¥75.8bn	¥36.7bn	3.8%	¥159.98	¥0.6bn
2023-03-31	¥51.0bn	¥1.6bn	¥72.5bn	¥35.6bn	4.6%	¥183.07	¥2.9bn
2022-03-31	¥49.6bn	¥1.5bn	¥69.3bn	¥34.5bn	4.3%	¥169.09	¥3.5bn

Indicators

Computed by us from filings · fiscal year to 2026-03-31

Metric	Value	Percentile among listed companies
ROE, %	5.9	31.2
Ordinary margin	0.0377	29.5
Equity ratio, %	38.8	25.1
Revenue growth	0.0288	38.6
Net income growth	1.6116	91
Operating cash flow / assets	-0.0689	6.3

Policy-uncertainty measure1.79 Share of the report's text discussing policy-related uncertainty, by policy area. Proprietary text method.

Trade & tariffs 2 Regulation 1 Politics & geopolitics 2

Ownership activity 0 filer(s) stated they may make proposals in 365 days; 0 new 5% holder(s) in 180 days; net stake change 0.00pt in 90 days; 4.2% held by other listed companies.

Results wording balance: -0.33. Proprietary text method; it describes the wording only and does not interpret context.

Interest example: if all ¥28.5bn of reported debt repriced by 50 basis points, a year's interest would rise by ¥142m. Our arithmetic only, not a forecast: fixed-rate debt and hedges are ignored.

Via /v1/companies/4538/indicators. Descriptive figures, not a rating and not investment advice.

From other filings

As the company states them

Internal control, 2026-06-23: see filing 上記の評価の結果、当事業年度末日時点において、当社の財務報告に係る内部統制は有効であると判断いたしました。 Filing

Segments, votes and tender offers

Stated in EDINET filings

Latest voting result: 2026-06-24 · 剰余金の処分の件 · passed. /v1/companies/4538/voting

Ownership changes

All companies →

2026-06-05

Below 5%−2.20pt

SMBC Nikko Securities Inc. cut holdings in Fuso Pharmaceutical Industries,Ltd. (4538) to 3.98% from 6.18%, below the 5% threshold.

S100Y8Q1Filer profile Original filing (PDF, Japanese)
2026-06-04

Decrease−0.08pt

Sumitomo Mitsui Trust Bank,Limited reduced holdings in Fuso Pharmaceutical Industries,Ltd. (4538) to 5.18% from 5.26%.

S100Y7YSFiler profile Original filing (PDF, Japanese)
2026-02-06

New 5% stake

SMBC Nikko Securities Inc. disclosed a 6.18% stake in Fuso Pharmaceutical Industries,Ltd. (4538), crossing the 5% reporting threshold.

S100XJKDFiler profile Original filing (PDF, Japanese)
2026-02-05

Decrease−0.14pt

Sumitomo Mitsui Trust Bank,Limited reduced holdings in Fuso Pharmaceutical Industries,Ltd. (4538) to 5.26% from 5.40%.

S100XITXFiler profile Original filing (PDF, Japanese)
2025-09-19

Decrease−0.27pt

Sumitomo Mitsui Trust Bank,Limited reduced holdings in Fuso Pharmaceutical Industries,Ltd. (4538) to 5.40% from 5.67%.

S100WPEJFiler profile Original filing (PDF, Japanese)
2025-05-22

Below 5%−1.99pt

SMBC Nikko Securities Inc. cut holdings in Fuso Pharmaceutical Industries,Ltd. (4538) to 3.89% from 5.88%, below the 5% threshold.

S100VSD3Filer profile Original filing (PDF, Japanese)
2025-04-21

Decrease−0.01pt

Sumitomo Mitsui Trust Bank,Limited reduced holdings in Fuso Pharmaceutical Industries,Ltd. (4538) to 5.67% from 5.68%.

S100VMRDFiler profile Original filing (PDF, Japanese)
2025-03-21

Decrease−0.23pt

Sumitomo Mitsui Trust Bank,Limited reduced holdings in Fuso Pharmaceutical Industries,Ltd. (4538) to 5.68% from 5.91%.

S100VEXAFiler profile Original filing (PDF, Japanese)
2025-03-07

New 5% stake

SMBC Nikko Securities Inc. disclosed a 5.88% stake in Fuso Pharmaceutical Industries,Ltd. (4538), crossing the 5% reporting threshold.

S100VCXQFiler profile Original filing (PDF, Japanese)
2024-04-22

Below 5%−1.92pt

SMBC Nikko Securities Inc. cut holdings in Fuso Pharmaceutical Industries,Ltd. (4538) to 3.15% from 5.07%, below the 5% threshold.

S100TAXTFiler profile Original filing (PDF, Japanese)

5% filings

Large shareholding reports on 4538

Filed	Filer	Stake	Change	Stated purpose
2026-06-05	SMBC Nikko Securities Inc.	3.98%	−2.20pt	—
2026-06-04	Sumitomo Mitsui Trust Bank,Limited	5.18%	−0.08pt	strategic holding
2026-02-06	SMBC Nikko Securities Inc.	6.18%	—	—
2026-02-05	Sumitomo Mitsui Trust Bank,Limited	5.26%	−0.14pt	strategic holding
2025-09-19	Sumitomo Mitsui Trust Bank,Limited	5.40%	−0.27pt	strategic holding
2025-05-22	SMBC Nikko Securities Inc.	3.89%	−1.99pt	—
2025-04-21	Sumitomo Mitsui Trust Bank,Limited	5.67%	−0.01pt	strategic holding
2025-03-21	Sumitomo Mitsui Trust Bank,Limited	5.68%	−0.23pt	strategic holding
2025-03-07	SMBC Nikko Securities Inc.	5.88%	—	—
2024-04-22	SMBC Nikko Securities Inc.	3.15%	−1.92pt	—

Cross-shareholdings

From the annual report's status of shareholdings

Listed strategic holdings: 14 issues
Book value: ¥5.0bn
Sold in the year: ¥173m 1 issues
Bought in the year: — — issues
Mutual, both reports: 7
Held by listed cos.: 15

Holds	Book value	Shares vs. prior year	Mutual
Mitsubishi UFJ Financial Group, Inc. 8306	¥1,128m	0.0%	no
Sumitomo Mitsui Financial Group, Inc. 8316	¥1,081m	0.0%	no
Sumitomo Mitsui Trust Group, Inc. 8309	¥796m	0.0%	no
TOHO HOLDINGS CO.,LTD. 8129	¥447m	0.0%	both reports
Nippon Fine Chemical Co., Ltd. 4362	¥419m	0.0%	both reports
Alfresa Holdings Corporation 2784	¥362m	0.0%	both reports
3-D Matrix,Ltd. 7777	¥267m	0.0%	no
Hokuhoku Financial Group, Inc. 8377	¥206m	0.0%	both reports
Resona Holdings, Inc. 8308	¥92m	0.0%	no
ダイト㈱(注)2	¥69m	+100.0%	stated

Held by: MANAC Chemical Partners Co.,Ltd. 4360, Hokuhoku Financial Group, Inc. 8377, TOHO HOLDINGS CO.,LTD. 8129, SUZUKEN CO.,LTD. 9987, Alfresa Holdings Corporation 2784, Okayama Paper Industries Co.,Ltd. 3892, Nippon Fine Chemical Co., Ltd. 4362, Daito Pharmaceutical Co., Ltd. 4577, VITAL KSK HOLDINGS,INC. 3151, MEDIPAL HOLDINGS CORPORATION 7459, TSUMUGU Holdings, Inc. 3055, ASAHI PRINTING CO.,LTD. 3951 and 3 more

Purposes, all holdings and mutual flags via /v1/companies/4538/cross-holdings. Share changes include stock splits.

Major shareholders

As of fiscal year end 2026-03-31

Shareholder	Shares	Ratio
individual holder	599,000	7.02%
日本マスタートラスト信託銀行株式会社（信託口）	563,000	6.60%
敷島振興株式会社	452,000	5.30%
扶桑薬品工業従業員持株会	327,000	3.84%
株式会社三井住友銀行	278,000	3.27%
三井住友信託銀行株式会社	245,000	2.88%
individual holder	179,000	2.10%
日本生命保険相互会社	159,000	1.87%
中尾薬品株式会社	151,000	1.78%
内外化成株式会社	127,000	1.49%

U.S. funds holding 4538

SEC Form N-PORT, reports to 2026-07-31

20 U.S. funds held 136,499 shares worth $1.8m.

Fund	Shares	Value	% of fund	As of
DFA INTERNATIONAL SMALL CAP VALUE PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC	36,001	$0.5m	0.003%	2026-07-31
INTERNATIONAL CORE EQUITY 2 PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC	27,198	$0.4m	0.001%	2026-07-31
Dimensional International Small Cap Value ETF Dimensional ETF Trust	14,200	$0.2m	0.004%	2026-07-31
Dimensional International Small Cap ETF Dimensional ETF Trust	12,200	$0.2m	0.003%	2026-07-31
WisdomTree Japan SmallCap Dividend Fund WisdomTree Trust	11,500	$0.1m	0.040%	2026-06-30

Up to 25 funds per stock via the API.

Get this as JSON

GET /v1/companies/4538
GET /v1/companies/4538/financials
GET /v1/companies/4538/details
GET /v1/companies/4538/segments
GET /v1/companies/4538/voting
GET /v1/companies/4538/tender-offers
GET /v1/companies/4538/indicators
GET /v1/companies/4538/earnings-releases
GET /v1/events?ticker=4538
GET /v1/companies/4538/trades         
GET /v1/companies/4538/cross-holdings 
GET /v1/companies/4538/brief

Plans from $9 a month · Documentation